Stable Gold-Nanoparticle-Based Vaccine for the Targeted Delivery of Tumor-Associated Glycopeptide Antigens
Open Access
- 10 September 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Bio & Med Chem Au
- Vol. 1 (1), 31-43
- https://doi.org/10.1021/acsbiomedchemau.1c00021
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (HHSN261200800001E)
This publication has 104 references indexed in Scilit:
- Targeting of macrophage galactose‐type C‐type lectin (MGL) induces DC signaling and activationEuropean Journal of Immunology, 2012
- Enhanced Epimerization of Glycosylated Amino Acids During Solid-Phase Peptide SynthesisJournal of the American Chemical Society, 2012
- Recent Development in Carbohydrate Based Anticancer VaccinesJournal of Carbohydrate Chemistry, 2012
- Nanoparticle Delivery Systems in Cancer VaccinesPharmaceutical Research, 2010
- Recent development in carbohydrate-based cancer vaccinesCurrent Opinion in Chemical Biology, 2009
- Immunotherapy for cancer: synthetic carbohydrate-based vaccinesChemical Communications, 2009
- Increasing the Antigenicity of Synthetic Tumor‐Associated Carbohydrate Antigens by Targeting Toll‐Like ReceptorsChemBioChem, 2009
- Varied presentation of the Thomsen–Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticlesCarbohydrate Research, 2008
- Robust immune responses elicited by a fully synthetic three-component vaccineNature Chemical Biology, 2007
- Tumor‐associated carbohydrate antigens: A possible avenue for cancer preventionImmunology & Cell Biology, 2005